台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-兆豐-松德 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/249095100105110115120125May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

兆豐-松德 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/2800.001104.00100.50-11,752-0.06%
2025/03/2520105.0000.00104.50201,7191.16%
2025/03/121107.5000.00107.0011,6950.06%
2025/03/1100.002105.50107.00-21,697-0.12%
2025/03/061112.001115.50111.0001,6470.00%
2025/03/0500.001116.50115.50-11,645-0.06%
2025/03/045114.501112.50114.5041,6340.24%
2025/02/261114.504118.50115.50-31,553-0.19%
2025/02/2400.001115.50115.00-11,431-0.07%
2025/02/211111.001111.00113.0001,4120.00%
2025/02/1800.001110.00110.00-11,401-0.07%
2025/02/071118.002118.50120.50-11,351-0.07%
2025/02/064119.500.2119.00119.003.81,3290.29%
2025/02/051108.002.2109.82113.00-1.21,194-0.10%
2025/01/0600.002101.50101.50-21,259-0.16%
2025/01/03495.102697.5198.30-221,240-1.77%
2024/12/052095.001494.6094.6061,1700.51%
2024/12/0400.001594.6094.60-151,164-1.29%
2024/11/29497.100.298.3097.503.81,1360.33%
2024/11/28192.4000.0092.4011,1100.09%
2024/11/27296.1000.0094.1021,0950.18%
2024/11/26794.4900.0094.0071,0840.65%
2024/11/22196.50196.5093.8001,0310.00%
2024/11/156102.081101.0099.9059890.51%
2024/11/138107.1300.00106.5089460.85%
2024/11/0700.001104.00103.50-1852-0.12%
2024/11/063108.0000.00102.5038260.36%
2024/11/055105.5024101.50106.00-19782-2.43%
2024/11/044.2102.649105.06100.00-4.8758-0.63%
2024/11/016108.084.2109.24105.001.87300.25%
2024/10/3000.002101.00102.00-2617-0.32%
2024/10/292101.002100.75100.5006040.00%
2024/10/2800.005499.76102.00-54576-9.36%
2024/10/25298.9000.0097.4025130.39%
2024/10/247998.152100.7598.307749415.57%
2024/10/0800.00192.0091.10-1507-0.20%
2024/08/21186.5000.0086.6017460.13%
2024/07/2300.00594.1094.50-5720-0.69%
2024/07/2200.00292.0092.00-2718-0.28%
2024/07/160.297.0000.0097.000.26580.03%
2024/06/28196.10196.1097.5005810.00%
2024/06/190.293.8000.0093.800.26370.03%
2024/04/2500.00191.1090.60-11,449-0.07%
2024/04/1800.00193.6093.60-11,525-0.07%
2024/04/03199.00199.0099.0001,7770.00%
2024/04/025100.505100.5098.9001,7800.00%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章